Clinical Trials Directory

Trials / Unknown

UnknownNCT06147674

Evaluation of VQm PHM on Pulmonary Health Parameters for ICU

Evaluation of VQm Pulmonary Health Monitor™ on Pulmonary Health Parameters for Intensive Care Medicine

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Rostrum Medical Innovations Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to compare pulmonary health parameter measurements from the VQm PHM™ to existing clinical measurements. The main questions it aims to answer are: * Confirm the performance of non-invasive pulmonary health parameter shunt fraction value found on the VQm PHM™ when compared to available reference measurements. * Confirm the performance of non-invasive pulmonary health parameter pulmonary blood flow, functional residual capacity and physiological dead space found on the VQm PHM™ when compared to available reference measurements.

Detailed description

This is a multi-site, international, prospective, non-blinded, non-randomized, observational study. This study aims to compare measurements from the VQm PHM™ to existing clinical measurements, assess safety of the device and determine effects that standard clinical events have on the VQm PHM™ measurements. This study does not include changes to clinical care based on measurements from the VQm PHM™. Each patient will serve as their own control.

Conditions

Interventions

TypeNameDescription
DEVICEVQm Pulmonary Health Monitor™The VQm Pulmonary Health Monitor™ (may be referred to as the VQm PHM™) is a a Class IIa, Health Canada approved medical device used as an adjunct monitor and is non-life supporting, providing clinicians with measurements of pulmonary function parameters of mechanically ventilated adult patients. The measurements provided are: * Pulmonary Blood Flow (PBF) * Shunt Fraction (Qsi) * Dead space (VD): * Functional Residual Capacity (FRC)

Timeline

Start date
2024-01-15
Primary completion
2025-01-15
Completion
2025-03-31
First posted
2023-11-27
Last updated
2023-11-27

Locations

4 sites across 4 countries: United States, Austria, Czechia, France

Source: ClinicalTrials.gov record NCT06147674. Inclusion in this directory is not an endorsement.